Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Report

Global and Region Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：224
  • REPORT CODE：GMM969365
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoformmarket, defines the market attractiveness level of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform industry, describes the types of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market, the applications of major players and the market size, and deeply analyzes the current situation of the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market and the development prospects and opportunities of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market in Chapter 13.

    By Player:

    • Novartis AG

    • PIQUR Therapeutics AG

    • AstraZeneca Plc

    • Karus Therapeutics Ltd

    • Bayer AG

    • GlaxoSmithKline Plc

    • Curis Inc

    By Type:

    • PQR-514

    • KA-2237

    • GSK-2636771

    • BAY-1082439

    • Others

    By End-User:

    • Gastric Cancer

    • Metastatic Colorectal Cancer

    • Myelofibrosis

    • Renal Cell Carcinoma

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Analysis and Outlook to 2022

    • 7.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    • 7.2 United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    • 7.3 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    • 7.4 China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    • 7.5 Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    • 7.6 India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    • 7.7 South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption (2017-2022)

    8 Region and Country-wise Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Analysis and Outlook to 2028

    • 8.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    • 8.2 United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    • 8.3 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    • 8.4 China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    • 8.5 Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    • 8.6 India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    • 8.7 South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast (2022-2028)

    9 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Outlook by Types and Applications to 2022

    • 9.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global PQR-514 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global KA-2237 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global GSK-2636771 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global BAY-1082439 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Gastric Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Myelofibrosis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Renal Cell Carcinoma Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Outlook by Types and Applications to 2028

    • 10.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global PQR-514 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global KA-2237 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global GSK-2636771 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global BAY-1082439 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Myelofibrosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Renal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Competitive Analysis

    • 14.1 Novartis AG

      • 14.1.1 Novartis AG Company Details

      • 14.1.2 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • 14.2 PIQUR Therapeutics AG

      • 14.2.1 PIQUR Therapeutics AG Company Details

      • 14.2.2 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • 14.3 AstraZeneca Plc

      • 14.3.1 AstraZeneca Plc Company Details

      • 14.3.2 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • 14.4 Karus Therapeutics Ltd

      • 14.4.1 Karus Therapeutics Ltd Company Details

      • 14.4.2 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • 14.5 Bayer AG

      • 14.5.1 Bayer AG Company Details

      • 14.5.2 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • 14.6 GlaxoSmithKline Plc

      • 14.6.1 GlaxoSmithKline Plc Company Details

      • 14.6.2 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • 14.7 Curis Inc

      • 14.7.1 Curis Inc Company Details

      • 14.7.2 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform

    • Figure Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Picture

    • Table Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption by Country (2017-2022)

    • Figure United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate (2017-2022)

    • Table Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate (2017-2022)

    • Figure China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate (2017-2022)

    • Figure Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate (2017-2022)

    • Figure India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate (2017-2022)

    • Figure South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption and Growth Rate (2017-2022)

    • Figure Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast by Country (2022-2028)

    • Figure United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PQR-514 Consumption and Growth Rate (2017-2022)

    • Figure Global KA-2237 Consumption and Growth Rate (2017-2022)

    • Figure Global GSK-2636771 Consumption and Growth Rate (2017-2022)

    • Figure Global BAY-1082439 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Gastric Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Myelofibrosis Consumption and Growth Rate (2017-2022)

    • Figure Global Renal Cell Carcinoma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global PQR-514 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global KA-2237 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global GSK-2636771 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BAY-1082439 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastric Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Myelofibrosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Renal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • Table PIQUR Therapeutics AG (Foundation Year, Company Profile and etc.)

    • Table PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • Table Karus Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service

    • Table Curis Inc (Foundation Year, Company Profile and etc.)

    • Table Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US